A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 23,974 shares of ACAD stock, worth $354,575. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,974
Previous 23,990 0.07%
Holding current value
$354,575
Previous $443,000 12.19%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

SELL
$14.62 - $18.42 $233 - $294
-16 Reduced 0.07%
23,974 $389,000
Q1 2024

Apr 25, 2024

BUY
$17.79 - $30.86 $10,407 - $18,053
585 Added 2.5%
23,990 $443,000
Q3 2023

Oct 25, 2023

BUY
$20.84 - $33.47 $53,100 - $85,281
2,548 Added 12.22%
23,405 $487,000
Q2 2023

Aug 07, 2023

BUY
$17.8 - $25.65 $65,575 - $94,494
3,684 Added 21.45%
20,857 $499,000
Q1 2023

May 08, 2023

SELL
$16.32 - $20.92 $12,337 - $15,815
-756 Reduced 4.22%
17,173 $323,000
Q4 2022

Feb 01, 2023

BUY
$14.2 - $18.63 $40,228 - $52,778
2,833 Added 18.77%
17,929 $285,000
Q2 2022

Aug 09, 2022

SELL
$13.01 - $27.22 $36,831 - $77,059
-2,831 Reduced 15.79%
15,096 $213,000
Q1 2022

Apr 21, 2022

BUY
$20.94 - $27.5 $27,933 - $36,685
1,334 Added 8.04%
17,927 $434,000
Q4 2021

Feb 01, 2022

BUY
$16.79 - $27.09 $58,748 - $94,787
3,499 Added 26.72%
16,593 $387,000
Q1 2021

May 03, 2021

SELL
$25.02 - $54.99 $40,006 - $87,929
-1,599 Reduced 10.88%
13,094 $338,000
Q4 2020

Jan 28, 2021

BUY
$41.04 - $56.79 $61,806 - $85,525
1,506 Added 11.42%
14,693 $785,000
Q2 2020

Jul 28, 2020

BUY
$39.26 - $52.73 $115,699 - $155,395
2,947 Added 28.78%
13,187 $639,000
Q1 2020

May 06, 2020

BUY
$31.65 - $46.87 $78,428 - $116,143
2,478 Added 31.92%
10,240 $433,000
Q4 2019

Jan 21, 2020

BUY
$36.21 - $51.4 $49,426 - $70,161
1,365 Added 21.34%
7,762 $332,000
Q1 2019

Apr 29, 2019

SELL
$16.17 - $27.38 $24,869 - $42,110
-1,538 Reduced 19.38%
6,397 $172,000
Q4 2018

Jan 25, 2019

BUY
$14.32 - $22.92 $32,105 - $51,386
2,242 Added 39.38%
7,935 $128,000
Q1 2018

May 03, 2018

SELL
$22.47 - $32.33 $38,423 - $55,284
-1,710 Reduced 23.1%
5,693 $128,000
Q4 2017

Jan 31, 2018

BUY
$26.84 - $39.14 $46,513 - $67,829
1,733 Added 30.56%
7,403 $223,000
Q3 2017

Nov 08, 2017

BUY
$29.49 - $38.37 $167,208 - $217,557
5,670
5,670 $214,000

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.39B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.